key: cord-0871212-2cl42hxp
authors: Nasiri, Kaveh; Dimitrova, Aleksandra
title: The role of povidone-iodine in managing of SARS-CoV-2 pandemic
date: 2022-03-18
journal: J Dent Sci
DOI: 10.1016/j.jds.2022.03.003
sha: db487af0d844156432d985d54c6b68c494e26932
doc_id: 871212
cord_uid: 2cl42hxp

nan

Currently, the worldwide management of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is mainly based on vaccination coverage and prevention strategies such as medical masks, social distancing, hand sanitizers, and telemedicine. SARS-CoV-2 can be transmitted in the upper respiratory tract, i.e., the nasal and oral cavities. Since vaccination coverage is not the same globally and the virus has high mutation potential and evades the vaccine, primary disinfection in the nasal and oral cavity is highly considered in reducing the viral load of COVID-19. In this regard, preliminary povidone-iodine (PVP-I) data have shown satisfactory results in eliminating the virus. [1] [2] [3] Hence, this brief letter attempts to highlight the efficacy of PVP-I against SARS-CoV-2.

PVP-I is a complex of three elements, namely povidone, hydrogen iodide, and elemental iodine. After releasing free iodine (I2) from PVP-I (C6H9I2NO), I2 can penetrate the microorganisms, thereby destroying two of their main components (i.e., proteins and oxidized nucleic acid) and resulting in an antimicrobial effect. PVP-I is used as an antiseptic against microorganisms such as gram-positive and gram-negative bacteria, fungus, and viruses (i.e., herpes, rubella, mumps, and respiratory viruses). As a pre-surgical skin antiseptic, it acts rapidly after being applied to the skin. It is also used as an oral and nasal antiseptic to deal with mucositis and oropharyngeal infections and prevent respiratory diseases related to pneumonia. 3, 4 The following recent studies have compared the effectiveness of PVP-I with other mouthwashes against COVID-19. In a comprehensive systematic review of 23 studies, Silva 

Omicron variant in the current SARS-CoV-2 pandemic

Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial

Use of mouthwashes against COVID-19 in dentistry

Can povidone iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update

The effect of mouthwashes on SARS-CoV-2 viral load: a systematic review

In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial

Povidone iodine (PVP-I) oro-nasal spray: an effective shield for COVID-19 protection for health care worker (HCW), for all

Gargling with povidone iodine has a short-term inhibitory effect on SARS-CoV-2 in patients with COVID-19

Oral transmucosal absorption of iodine after intraoral preparation with povidone-iodine prior to oral surgeries: a randomized controlled study in 12 male patients

The efficacy of diluted topical povidoneiodine rinses in the management of recalcitrant chronic rhinosinusitis: a prospective cohort study

This brief letter has not been published and is not under consideration for publication elsewhere. We guarantee that no intentional or unintentional plagiarism has occurred. We also confirm that all figures and tables are original and created by the authors of this study. I attest to the fact that all authors listed on the title page have read the manuscript, attest to the validity and legitimacy of the data and its interpretation, and agree to its submission to Journal of Dental Sciences. We have no conflicts of interest.